Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 5. Oseltamivir carboxylate

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The aim of this study was to determine the biopharmaceutical characteristics of oseltamivir carboxylate (OC) after pulmonary delivery. After OC bolus and intratracheal nebulization (NEB) in rats, blood was collected and bronchoalveolar lavages (BALs) were performed. Epithelial lining fluid (ELF) concentrations were estimated from BAL fluid. The area under the curve (AUC) ratio for ELF to plasma was 842 times higher after NEB than after intravenous (i.v.) administration, indicating that OC nebulization offers a biopharmaceutical advantage over i.v. administration.

Cite

CITATION STYLE

APA

Galindo Bedor, D. C., Marchand, S., Lamarche, I., Laroche, J., Pereira De Santana, D., & Couet, W. (2016). Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 5. Oseltamivir carboxylate. Antimicrobial Agents and Chemotherapy, 60(8), 5085–5087. https://doi.org/10.1128/AAC.00909-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free